 |
PDBsum entry 3eot
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
3eot
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Protein Eng Des Sel
22:93
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
|
|
L.A.Clark,
P.A.Boriack-Sjodin,
E.Day,
J.Eldredge,
C.Fitch,
M.Jarpe,
S.Miller,
Y.Li,
K.Simon,
H.W.van Vlijmen.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
A design approach was taken to investigate the feasibility of replacing single
complementarity determining region (CDR) antibody loops. This approach may
complement simpler mutation-based strategies for rational antibody design by
expanding conformation space. Enormous crystal structure diversity is available,
making CDR loops logical targets for structure-based design. A detailed analysis
for the L1 loop shows that each loop length takes a distinct conformation,
thereby allowing control on a length scale beyond that accessible to simple
mutations. The L1 loop in the anti-VLA1 antibody was replaced with the L2 loop
residues longer in an attempt to add an additional hydrogen bond and fill space
on the antibody-antigen interface. The designs expressed well, but failed to
improve affinity. In an effort to learn more, one design was crystallized and
data were collected at 1.9 A resolution. The designed L1 loop takes the
qualitatively desired conformation; confirming that loop replacement by design
is feasible. The crystal structure also shows that the outermost loop (residues
Leu51-Ser68) is domain swapped with another monomer. Tryptophan fluorescence
measurements were used to monitor unfolding as a function of temperature and
indicate that the loop involved in domain swapping does not unfold below 60
degrees C. The domain-swapping is not directly responsible for the affinity
loss, but is likely a side-effect of the structural instability which may
contribute to affinity loss. A second round of design was successful in
eliminating the dimerization through mutation of a residue (Leu51Ser) at the
joint of the domain-swapped loop.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
R.J.Pantazes,
and
C.D.Maranas
(2010).
OptCDR: a general computational method for the design of antibody complementarity determining regions for targeted epitope binding.
|
| |
Protein Eng Des Sel,
23,
849-858.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |
|